{"title": "Prostate cancer immunotherapy - IOZK", "author": "Root", "url": "https://www.iozk.de/2011/06/prostate-cancer-immunotherapy/", "hostname": "iozk.de", "description": "PMID: 21700764 Journal: Clinical cancer research : an official journal of the American Association for Cancer Research (volume: 17, issue: 16, Clin. Cancer Res. 2011 Aug;17(16):5233-8) Published: 2011-06-23 Authors: May KF, Gulley JL, Drake CG, Dranoff G, Kantoff PW ABSTRACT The interaction between the immune system and prostate cancer has been an area of research [\u2026]", "sitename": "IOZK", "date": "2011-06-23", "id": null, "license": null, "body": null, "comments": "", "commentsbody": null, "raw_text": null, "text": "[Prostate cancer immunotherapy ](https://www.iozk.de/2011/06/prostate-cancer-immunotherapy/)\nABSTRACT\nThe interaction between the immune system and prostate cancer has been an area of research interest for several decades. The recent U.S. Food and Drug Administration approval of 2 first-in-class proof-of-concept immunotherapies (sipuleucel-T and ipilimumab) has stimulated broader interest in manipulating immunity to fight cancer. In the context of prostate cancer, the immunotherapy strategies that have garnered the most interest are the therapeutic vaccination strategies, exemplified by sipuleucel-T and PROSTVAC-VF, and immune checkpoint blockade of CTLA-4 and PD-1. Improved understanding of the immune responses generated by these strategies and development of predictive biomarkers for patient selection will guide rational combinations of these treatments and provide building blocks for future immunotherapies.", "language": null, "image": null, "pagetype": "article", "links": ["https://www.iozk.de/en/", "https://www.iozk.de/es/", "https://www.primomedico.com/fr/medecin/iozk-centre-immunologie-et-oncologie-de-cologne/", "https://www.iozk.de/ru/", "https://www.iozk.de/pl/", "https://www.primomedico.com/ar/tabib/iozk-mrkz-elm-almnaep-alsrtany-fy-koln/", "mailto:info@iozk.de", "https://www.iozk.de/2011/06/prostate-cancer-immunotherapy/", "https://www.iozk.de/en/", "https://www.iozk.de/es/", "https://www.iozk.de/ru/", "https://www.iozk.de/pl/", "https://www.iozk.de/", "/", "#", "https://www.iozk.de/immuntherapie-gegen-krebs/philosophie/", "https://www.iozk.de/immuntherapie-gegen-krebs/team-iozk/", "https://www.iozk.de/immuntherapie-gegen-krebs/behandlungszentrum/", "https://www.iozk.de/immuntherapie-gegen-krebs/laboratorien/", "https://www.iozk.de/karriere/", "https://www.iozk.de/anreise/", "https://www.iozk.de/patientenbroschuere/", "#", "https://www.iozk.de/die-iozk-immuntherapie/iozk-immuntherapie/", "https://www.iozk.de/die-iozk-immuntherapie/io-vac-impfstoff/", "https://www.iozk.de/die-iozk-immuntherapie/behandlungsablauf/", "https://www.iozk.de/die-iozk-immuntherapie/therapieverlauf-nach-krebsarten/", "https://www.iozk.de/immuntherapie-gegen-krebs/therapiekosten/", "https://www.iozk.de/die-iozk-immuntherapie/faq/", "#", "https://www.iozk.de/iozk-publikationen/", "https://www.iozk.de/publikationen/", "https://www.iozk.de/fachwissen/", "https://www.iozk.de/aktuelles/", "https://www.iozk.de/kontakt/", "?s=", "#", "https://www.iozk.de/2011/06/prostate-cancer-immunotherapy/", "https://www.iozk.de/category/publications/dendritic-cells/", "https://www.iozk.de/category/publications/", "https://www.iozk.de/category/publications/prostate-cancer/", "#", "https://www.ncbi.nlm.nih.gov/pubmed/21700764", "mailto:?subject=Prostate%20cancer%20immunotherapy&body=https://www.iozk.de/2011/06/prostate-cancer-immunotherapy/", "https://www.iozk.de/2023/05/efficacy-of-a-dual-epitope-dendritic-cell-vaccine-as-part-of-combined-immunotherapy-for-her2-expressing-breast-tumors/", "https://www.iozk.de/2023/05/autologous-dendritic-cells-loaded-with-antigens-from-self-renewing-autologous-tumor-cells-as-patient-specific-therapeutic-cancer-vaccines/", "https://www.iozk.de/2023/04/dendritic-cell-vaccines-in-breast-cancer-immune-modulation-and-immunotherapy/", "https://www.iozk.de/portfolio-item/evidenzbasierte-medizin-am-iozk/", "https://www.iozk.de/portfolio-item/laboratorien-am-iozk/", "https://www.iozk.de/portfolio-item/magazin-der-iozk-stiftung-consilium/", "https://www.iozk.de/portfolio-item/video-patient-berichtet-ueber-die-erfahrungen-mit-der-iozk-immuntherapie/", "https://www.iozk.de/portfolio-item/video-patientin-frau-ebel-ueber-ihre-erfahrungen-mit-der-iozk-immuntherapie/", "https://www.iozk.de/portfolio-item/video-immunologische-krebstherapie-am-iozk-in-koeln/", "https://www.iozk.de/portfolio-item/informationsbroschuere-der-iozk-stiftung/", "https://www.iozk.de/portfolio-item/personalisierte-medizin-am-iozk/", "https://www.iozk.de/portfolio-item/die-entstehung-von-krebs/", "https://www.iozk.de/portfolio-item/was-bedeutet-immuntherapie/", "https://www.iozk.de/portfolio-item/nobelpreise-fuer-immuntherapie/", "https://www.iozk.de/portfolio-item/curcumin-in-der-medizinischen-anwendung/", "https://www.iozk.de/portfolio-item/virotherapie-mit-viren-gegen-den-krebs/", "https://www.iozk.de/portfolio-item/dendritische-zellen-informieren-das-immunsystem/", "https://www.iozk.de/portfolio-item/hyperthermie-mit-waerme-gegen-krebs/", "https://www.iozk.de/tag/brustkrebs/", "https://www.iozk.de/tag/case-report/", "https://www.iozk.de/tag/check-point-inibitoren/", "https://www.iozk.de/tag/chemotherapie/", "https://www.iozk.de/tag/curamun/", "https://www.iozk.de/tag/curcumin/", "https://www.iozk.de/tag/dendritische-zellen/", "https://www.iozk.de/tag/dr-dirk-lorenzen/", "https://www.iozk.de/tag/dr-wilfried-stuecker/", "https://www.iozk.de/tag/evidenzbasierte-medizin/", "https://www.iozk.de/tag/fluessigbiopsie/", "https://www.iozk.de/tag/german-medical-award/", "https://www.iozk.de/tag/glioblastom/", "https://www.iozk.de/tag/hirntumor/", "https://www.iozk.de/tag/hyperthermie/", "https://www.iozk.de/tag/immuntherapie/", "https://www.iozk.de/tag/io-vac/", "https://www.iozk.de/tag/iozk-symposium/", "https://www.iozk.de/tag/iozk-arbeitsgruppe/", "https://www.iozk.de/tag/iozk-immuntherapie/", "https://www.iozk.de/tag/iozk-patientenbroschuere/", "https://www.iozk.de/tag/iozk-stiftung/", "https://www.iozk.de/tag/newcastle-disease-virus/", "https://www.iozk.de/tag/nobelpreis-fuer-medizin/", "https://www.iozk.de/tag/onkologie/", "https://www.iozk.de/tag/onkolytische-viren/", "https://www.iozk.de/tag/paul-ehrlich-preis/", "https://www.iozk.de/tag/personalisierte-medizin/", "https://www.iozk.de/tag/ponsgliom/", "https://www.iozk.de/tag/prof-dr-rer-nat-volker-schirrmacher/", "https://www.iozk.de/tag/prostatakrebs/", "https://www.iozk.de/tag/publikationen-dr-wilfried-stuecker/", "https://www.iozk.de/tag/publikationen-prof-dr-rer-nat-volker-schirrmacher/", "https://www.iozk.de/tag/publikationen-stefaan-van-gool-md-phd/", "https://www.iozk.de/tag/stefaan-van-gool/", "https://www.iozk.de/tag/target-therapie/", "https://www.iozk.de/tag/virotherapie/", "tel:004922142039925", "mailto:info@iozk.de", "https://www.iozk.de/immuntherapie-gegen-krebs/philosophie/", "https://www.iozk.de/immuntherapie-gegen-krebs/team-iozk/", "https://www.iozk.de/immuntherapie-gegen-krebs/behandlungszentrum/", "https://www.iozk.de/immuntherapie-gegen-krebs/laboratorien/", "https://www.iozk.de/karriere/", "https://www.iozk.de/anreise/", "https://www.iozk.de/patientenbroschuere/", "https://www.iozk.de/die-iozk-immuntherapie/iozk-immuntherapie/", "https://www.iozk.de/die-iozk-immuntherapie/io-vac-impfstoff/", "https://www.iozk.de/die-iozk-immuntherapie/behandlungsablauf/", "https://www.iozk.de/die-iozk-immuntherapie/therapieverlauf-nach-krebsarten/", "https://www.iozk.de/immuntherapie-gegen-krebs/therapiekosten/", "https://www.iozk.de/die-iozk-immuntherapie/faq/", "https://www.iozk.de/2023/05/efficacy-of-a-dual-epitope-dendritic-cell-vaccine-as-part-of-combined-immunotherapy-for-her2-expressing-breast-tumors/", "https://www.iozk.de/2023/05/autologous-dendritic-cells-loaded-with-antigens-from-self-renewing-autologous-tumor-cells-as-patient-specific-therapeutic-cancer-vaccines/", "https://www.iozk.de/2023/04/dendritic-cell-vaccines-in-breast-cancer-immune-modulation-and-immunotherapy/", "https://www.iozk.de/impressum/", "https://www.iozk.de/datenschutzerklaerung/", "https://www.iozk.de/datenschutz/#BorCook", "https://www.iozk.de/presse/", "#top"]}